Target intelligence / Profile preview

Cellular DNA and macromolecules

Molecular classification
Nucleic acid, Protein, Lipid
01

Overview

Cellular DNA and macromolecules within alpha-particle range represent the primary biological substrates for Targeted Alpha Therapy (TAT). Alpha particles are heavy, positively charged helium nuclei emitted by radionuclides such as Actinium-225 or Radium-223. Due to their high linear energy transfer (LET) and short tissue range, typically 50-100 micrometers, they deposit intense energy along a very narrow track (Nelson et al., 2021, Pharmaceutics). This energy deposition causes severe, often irreparable damage to the genomic DNA, specifically through complex double-strand breaks, as well as the oxidation of proteins and lipids within the cell (Sgouros et al., 2020, Nature Reviews Drug Discovery). This localized destruction is highly effective at killing cancer cells while minimizing damage to distant healthy tissues, provided the alpha-emitting isotope is accurately delivered to the tumor site. The high biological effectiveness of alpha radiation ensures that even a few hits to the cell nucleus can be sufficient to induce cell death via apoptosis or mitotic catastrophe (Parker et al., 2018, Journal of Nuclear Medicine).

Other names
Nuclear DNAGenomic DNACellular proteinsCellular lipidsRadiation targets
02

Mechanism of action

Alpha particles deliver high linear energy transfer (LET) radiation, causing dense ionization along a short path (50-100 micrometers). This results in complex, clustered double-strand DNA breaks (DSBs) and oxidative damage to proteins and lipids, leading to cell death (Kim & Han, 2018, Applied Sciences).

03

Biological functions

Genetic information storageCellular structureMetabolismSignal transduction
04

Disease associations

Cancer
05

Safety considerations

MyelosuppressionNephrotoxicityXerostomiaBystander effectOff-target toxicity to healthy tissues within range
06

Interacting drugs

Radium-223 dichloride

5 more in the full profile.

07

Biomarkers

gamma-H2AX53BP1DNA double-strand breaks

Beyond the preview

Go deeper on Cellular DNA and macromolecules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular DNA and macromolecules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call